VISTA, Calif.--(BUSINESS WIRE)--Auspex Pharmaceuticals, Inc. (www.auspexpharma.com) announced today that it has signed a deal involving a promising deuterium-containing drug with Teva Pharmaceutical Industries, Ltd. The discovery and initial development of the program subject to this transaction was conducted at Auspex Pharmaceuticals. Terms of the transaction were not disclosed.
